Identification of prognostic biomarkers for cholangiocarcinoma by combined analysis of molecular characteristics of clinical MVI subtypes and molecular subtypes

联合分析临床MVI亚型分子特征与分子亚型寻找胆管癌预后生物标志物

阅读:20
作者:Ming-Yue Li, Ya-Hui Liu, Feng Wei, Ping Zhang, Xiao-Dong Sun, Meng Wang, Xiao-Hong Du, Jun-Feng Ye, Wei Qiu, Xiao-Ju Shi, Bai Ji, Ying-Chao Wang, Chao Jiang, Wen-Gang Chai, Bo Huang, Xing-Kai Liu, Qing-Min Chen, Yu Fu, Xin-Tong Hu, Li-Guo Chen, Jia-Xue He, Kai-Yuan Chai, Zhao-Ming Gou, Tian Yang, Gu

Abstract

Cholangiocarcinoma (CCA) is widely noted for its high degree of malignancy, rapid progression, and limited therapeutic options. This study was carried out on transcriptome data of 417 CCA samples from different anatomical locations. The effects of lipid metabolism related genes and immune related genes as CCA classifiers were compared. Key genes were derived from MVI subtypes and better molecular subtypes. Pathways such as epithelial mesenchymal transition (EMT) and cell cycle were significantly activated in MVI-positive group. CCA patients were classified into three (four) subtypes based on lipid metabolism (immune) related genes, with better prognosis observed in lipid metabolism-C1, immune-C2, and immune-C4. IPTW analysis found that the prognosis of lipid metabolism-C1 was significantly better than that of lipid metabolism-C2 + C3 before and after correction. KRT16 was finally selected as the key gene. And knockdown of KRT16 inhibited proliferation, migration and invasion of CCA cells.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。